Changes in AMPK and Akt/mTOR signaling pathways, as a mechanism of oxaliplatin resistance, were examined in oxaliplatin-resistant (OR) CRC cells, extending the investigation of their effects on enzymes involved in glycolysis during the acquisition of oxaliplatin resistance in CRC cells. The gene discussed is MTOR; the disease is colorectal carcinoma.